How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing Via CTDMO Services
Source: MilliporeSigma
In this webinar, gain valuable insights into key factors to consider when selecting lipid excipients for lipid nanoparticle (LNP) formulations. Additionally, you will learn about the process development steps necessary for advancing LNP formulations to GMP manufacturing and clinical trials.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
Subscribe to Advancing RNA
X
Subscribe to Advancing RNA
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more